Wu Capital — Full Portfolio
8 tracked investments · listed companies and verified rows first
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.
BiotechHealthtechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in
Co-investorsAtlas VentureMC Healthcare VenturesNew Enterprise Associates (NEA)AlexandriaQiming Venture PartnersQiming Venture Partners USA+3 more
Laiye offers a Work Execution Platform that lets government and enterprise clients build LLM-driven digital workforces, combining RPA, conversational AI, and intelligent document processing to automate business processes.
AI & Machine LearningEnterprise SoftwareSaaSBeijing, CN
Yichuan Hu(Founder)in
Co-investorsCathay InnovationDCP CapitalLightspeed Venture PartnersSequoia CapitalZhenFundActivant Capital+2 more
Aries offers a trading platform where users can trade individual stocks, ETFs, options, and index options in a single application.
Data & InfrastructureDeveloper ToolsFintechSaaS
RedaPash
Co-investorsID VenturesMichigan RiseShenzhen Capital GroupVision Plus CapitalYunqi Partners
Cobo is a digital asset infrastructure company that provides custody and wallet technology, including Wallet-as-a-Service, to help organizations and developers manage and secure cryptocurrency and digital assets.
Crypto & Web3Data & InfrastructureEnterprise SoftwareFintechHong Kong, HK
Changhao Jiang(CTO and Co-founder)inLily Z. KinginMao Shixing(CEO and Co-founder)
Co-investorsDST GlobalIMO VenturesBitDAOBN CapitalCyberport Hong KongLinear Capital+3 more
Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
BiotechHealthtechMedical Devices
Brian Farmer(Co-Founder, Chief Executive Officer)inHeather Hsu, PhD(Co-Founder, Chief Scientific Officer)Michael Gallatin, PhD(Co-Founder, SAB Chair)Chuhan Chung(Chief Medical Officer)in
Co-investors5AM VenturesFrazier Life SciencesFrazier Healthcare Partners
Ping is a fintech platform offering free USD accounts and global payment solutions for freelancers and international workers.
Crypto & Web3FintechBuenos Aires, AR
Mary Saracco(Founder)inPablo Orlando(Founder)inJack Saracco(Founder)inNico BayerquePablo Orlandoin
Co-investorsY CombinatorGeneral CatalystGoat CapitalLightspeed Venture PartnersLuminous VenturesRibbit Capital+1 more
Sanjieke is a China-based digital talent training provider that offers online learning platforms and courses to enterprises and individuals for digital transformation and workforce upskilling.
AI & Machine LearningEdTechEnterprise SoftwareSaaSBeijing, CN
后显慧 (Luke Hou)(Founder & CEO)徐财星(Founder)in
Co-investorsOwl VenturesIDG CapitalUdemy
Cambridge, MA biotech developing stem cell-derived islet therapy plus an immune-protective device for type 1 diabetes; acquired by Vertex for $950M.
BiotechCambridge, US
Robert Millman(Executive Officer, Director)
BoardTodd Foley(Executive Officer, Director)inMitch Finer(Director)Stephen Knight(Director)inJim Scopa(Director)William Sahlman(Director)
Co-investorsARCH Venture PartnersF-Prime CapitalJDRF T1D FundORI CapitalSlater Technology Fund6 Dimensions Capital+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
































.png)






